pyrroles has been researched along with Psychoses in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (50.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Chen, JC; Liao, IM | 1 |
Gosek, P; Heitzman, J; Lechowicz, W; Stępień, T; Wardeński, R | 1 |
Kunene, V; Porfiri, E | 1 |
Borsini, F; Campiani, G; Carminati, P; Di Serio, S; Ghirardi, O; Minetti, P; Schiavone, A; Stasi, MA; Vertechy, M | 1 |
Dimitri, E; Landry, P; Légaré, N; Tessier, S | 1 |
Graham, DJ; Moore, MR | 1 |
Chari, S; Deth, RC; DuRand, CJ; Kotb, M; Kramer, ML; Liu, D; Nagata, M; Ouellette, D; Sharma, A; Shim, S; Tan, W; Wick, PF | 1 |
Clifford, JJ; Waddington, JL | 1 |
Durkó, I; Huszák, I; Karsai, K | 1 |
Angrist, BM; Floyd, A; Gershon, S | 1 |
Russell, CS | 1 |
Bayne, W; Irvine, DG; Majer, JR; Miyashita, H | 1 |
Berger, JG; Pachter, IJ; Teller, SR | 1 |
Beck, R; Noval, JJ; Sohler, A | 1 |
14 other study(ies) available for pyrroles and Psychoses
Article | Year |
---|---|
Lack of dopamine D4 receptor participation in mouse hyperdopaminergic locomotor response.
Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Sensitization; Clozapine; Disease Models, Animal; Dopamine Agents; Locomotion; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Transgenic; Psychotic Disorders; Pyridines; Pyrroles; Receptors, Dopamine D4 | 2021 |
Elevated hydroxylactam of hemopyrrole level in urine in perpetrators of extremely violent acts diagnosed with psychosis.
Topics: Adult; Aggression; Criminals; Humans; Male; Middle Aged; Psychotic Disorders; Pyrroles; Risk Factors | 2017 |
Sunitinib-induced acute psychosis: case report.
Topics: Aged; Bipolar Disorder; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Psychotic Disorders; Pyrroles; Sunitinib | 2011 |
ST2472: a new potential antipsychotic with very low liability to induce side-effects.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Blood Pressure; Catalepsy; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation; Heart Rate; Hyperkinesis; Locomotion; Male; Motor Activity; Piperazines; Prolactin; Psychotic Disorders; Pyrroles; Rats; Rats, Inbred F344; Reaction Time; Statistics, Nonparametric; Stereotyped Behavior; Thiazepines | 2008 |
Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
Topics: Adult; Antipsychotic Agents; Atorvastatin; Cholesterol; Clozapine; Female; Fenofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Psychotic Disorders; Pyrroles; Retrospective Studies; Schizophrenia; Treatment Outcome; Triglycerides | 2008 |
Monopyrroles in porphyria, psychosis and lead exposure.
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Aminolevulinic Acid; Animals; Heme Oxygenase (Decyclizing); Humans; Lead Poisoning; Leukocytes; Liver; Male; Porphyrias; Porphyrins; Psychotic Disorders; Pyrroles; Rats | 1980 |
D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia.
Topics: Amino Acid Sequence; Aminopyridines; Animals; Benzazepines; Binding Sites; Carbon Radioisotopes; CHO Cells; Clozapine; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Formates; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Methionine; Mutagenesis, Site-Directed; Neuroblastoma; Phospholipids; Phosphorylation; Piperidines; Psychotic Disorders; Pyridines; Pyrroles; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; S-Adenosylmethionine; Salicylamides; Schizophrenia; Transfection; Tumor Cells, Cultured | 1999 |
Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonists.
Topics: Animals; Behavior, Animal; Brain; Brain Mapping; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Habituation, Psychophysiologic; Male; Psychotic Disorders; Pyrazines; Pyridines; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D4 | 2000 |
Experimental data to the pathogenesis of cryptopyrrole excretion in schizophrenia, I.
Topics: Chromatography; Depression; Epilepsy; Humans; Mass Screening; Paranoid Disorders; Periodicity; Porphyrins; Psychotic Disorders; Pyrroles; Schizophrenia; Tryptophan | 1972 |
Psycho-activating effects of a new anticonvulsant--CM-6.
Topics: Adult; Anticonvulsants; Chemical Phenomena; Chemistry; Female; Humans; Male; Middle Aged; Psychological Tests; Psychotic Disorders; Pyrroles | 1968 |
Biosynthesis of porphyrins and the origin of the "mauve factor".
Topics: Ammonia; Deamination; Humans; Isomerases; Porphyrins; Psychotic Disorders; Pyrroles; Transaminases | 1972 |
Identification of kryptopyrrole in human urine and its relation to psychosis.
Topics: Animals; Chromatography, Thin Layer; Humans; Psychotic Disorders; Pyrroles; Rats; Spectrum Analysis | 1969 |
Cycloalkapyrrolones via decarboxylative ring closure of pyrrole-3-alkanoic acids and derivatives.
Topics: Alkanes; Chemical Phenomena; Chemistry; Humans; Indoles; Ketones; Psychotic Disorders; Pyrroles; Spectrum Analysis | 1970 |
Mauve factor re-identified as 2,4-dimethyl-3-ethylpyrrole and its sedative effect on the CNS.
Topics: Animals; Central Nervous System; Charcoal; Chloroform; Chlorpromazine; Chromatography, Paper; Chromatography, Thin Layer; Humans; Hypnotics and Sedatives; Psychotic Disorders; Pyrroles; Rabbits; Spectrophotometry; Stimulation, Chemical; Trifluoperazine | 1970 |